ATUM is an industry-leading provider of life science tools and solutions. Founded as DNA2.0 in 2003, we were a pioneer in the application of machine learning to synthetic biology and currently hold multiple patents covering several technologies, including our first-to-market Leap-In Transposase® platform. Our integrated offerings include Gene Design & Synthesis, Protein Production, and Cell Line Development — all powered by our Leap-In Transposase® and machine learning platform. This means a streamlined path from sequence to Research Cell Bank (RCB) with just a click, ensuring efficiency, regulatory compliance, and innovative solutions tailored to our clients' needs. ATUM is privately held and is headquartered in Newark, CA.
| Website | http://www.atum.bio |
| Revenue | $18.5 million |
| Employees | 144 (102 on RocketReach) |
| Founded | 2003 |
| Address | 37950 Central Court, Newark, California 94560, US |
| Phone | +1 650-853-8347 |
| Industry | Biotechnology, Bioengineering, Genes, Proteins, Cell Lines |
| Keywords | Synthetic Biology, Gene Synthesis, Dna Synthesis, Life Science Tools, Biotechnology, Genetic Engineering, Molecular Biology, Machine Learning, Biotechnology Solutions, Dna Sequencing, Genome Editing, Crispr, Bioinformatics, Life Science Research, Pharmaceutical Research, Drug Discovery, Biotechnology Research, Genetic Research, Molecular Diagnostics, Oligonucleotide Synthesis |
| Competitors | Roche, Thermo Fisher Scientific, Boehringer Ingelheim, Agilent Technologies, Illumina, Bio-Rad Laboratories, QIAGEN, Eppendorf Group, New England Biolabs, Zymergen, Inc. +50 more (view full list) |
Looking for a particular ATUM employee's phone or email?
The ATUM annual revenue was $18.5 million in 2026.
Sridhar Govindarajan is the Co-Founder, CIO of ATUM.
102 people are employed at ATUM.
ATUM is based in Newark, California.